scispace - formally typeset
Journal ArticleDOI

Novel molecular profiles of endometrial cancer-new light through old windows.

Reads0
Chats0
TLDR
Despite the great effort made to establish a molecularly-based histological classification, the following issues must still be clarified: what triggers the tumor cells to invade the myometrium and what causes vascular or lymphatic dissemination, finally culminating in metastasis?
About
This article is published in The Journal of Steroid Biochemistry and Molecular Biology.The article was published on 2008-02-01. It has received 213 citations till now. The article focuses on the topics: Endometrial intraepithelial neoplasia & Endometrial cancer.

read more

Citations
More filters
Journal ArticleDOI

The molecular biology of endometrial cancers and the implications for pathogenesis, classification, and targeted therapies

TL;DR: The molecular basis for genesis of endometrioid endometrial cancer with regard to pathogenesis, classification, and implications for targeted therapies is reviewed.
Journal ArticleDOI

Factors associated with Type I and Type II endometrial cancer.

TL;DR: In this large retrospective cohort of patients with EC, the striking difference in risk factors associated with Type II vs. Type I tumors suggests that these subtypes represent different disease entities that require different treatment modalities.
Journal ArticleDOI

The microbiome and gynaecological cancer development, prevention and therapy

TL;DR: How dysbiosis could lead to malignancy and how cancer and its treatment can, in turn, affect the FRT microbiome are discussed, and how modulation of the microbiome might prove useful in improving responsiveness to cancer treatment and quality of life in women with gynaecological cancers are considered.
Journal ArticleDOI

Differential trends in the rising incidence of endometrial cancer by type: data from a UK population-based registry from 1994 to 2006

TL;DR: Increased incidence in endometrial cancer is confined to type 1 cancers, seen most in the 60–79 age groups and across all socioeconomic quintiles, andUrgent research is needed to investigate prevention strategies in type 1 and improve therapy in type 2 cancers.
Journal ArticleDOI

Should grade 3 endometrioid endometrial carcinoma be considered a type 2 cancer-a clinical and pathological evaluation.

TL;DR: G3 EEC is better characterised as type 2 cancer and should be treated with similar adjuvant therapy to UPSC/CC, which share similar clinical, immunohistochemistry and poor survival.
References
More filters
Journal ArticleDOI

Two pathogenetic types of endometrial carcinoma

TL;DR: The author presents a hypothesis that the complex of endocrine and metabolic disturbances arising long before the development of endometrial carcinoma determines the biological peculiarities of the tumor, its clinical course, and the prognosis of the disease.
Journal ArticleDOI

The Cytoplasmic Domain of the Cell Adhesion Molecule Uvomorulin Associates With Three Independent Proteins Structurally Related in Different Species

TL;DR: The characterization of 102, 88 and 80 kd proteins provides a first molecular basis for a possible cytoplasmic anchorage of uvomorulin to the cytoskeleton and proposes the nomenclature of catenin alpha, beta and gamma respectively.
Journal ArticleDOI

PI 3-kinase, Akt and cell survival.

TL;DR: Novel connections between the metabolic effects of Akt and its control of survival have recently been made and the mechanisms for PI 3-kinase survival signalling are becoming clear.
Journal ArticleDOI

Altered PTEN Expression as a Diagnostic Marker for the Earliest Endometrial Precancers

TL;DR: Loss of PTEN function by mutational or other mechanisms is an early event in endometrial tumorigenesis that may occur in response to known endocrine risk factors and offers an informative immunohistochemical biomarker for premalignant disease.
Related Papers (5)

Integrated genomic characterization of endometrial carcinoma

Gad Getz, +283 more
- 02 May 2013 -